We are live on
!
Find out more
Lyell Immunopharma
LYEL
LYEL
75 hedge funds and large institutions have $689M invested in Lyell Immunopharma in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
8,620% more call options, than puts
Call options by funds: $3.92M | Put options by funds: $45K
37% more capital invested
Capital invested by funds: $503M → $689M (+$186M)
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
0.08% more ownership
Funds ownership: 2.07% → 2.15% (+0.08%)
5% less funds holding
Funds holding: 79 → 75 (-4)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
Holders
75
Holders Change
-4
Holders Change %
-5.06%
% of All Funds
1.26%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
14
Increased
26
Reduced
19
Closed
16
Calls
$3.92M
Puts
$45K
Net Calls
+$3.88M
Net Calls Change
+$925K
Top Buyers
| 1 |
BlackRock
New York
|
+$11.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.46M |
| 3 |
MCMU
MIC Capital Management (UK)
London,
United Kingdom
|
+$8.89M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.6M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.16M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.42M |
| 2 |
AP
Adero Partners
Pleasanton,
California
|
-$1.28M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.26M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.02M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$866K |
